As of 2026-04-25, the Relative Valuation of Regeneron Pharmaceuticals Inc (REGN) is 779.15 USD. This relative valuation is based on P/E multiples. With the latest stock price at 751.57 USD, the upside of Regeneron Pharmaceuticals Inc based on Relative Valuation is 3.7%.
The range of the Relative Valuation is 609.35 - 923.18 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 17.8x | 16.1x |
| Forward P/E multiples | 17.6x - 19.6x | 18.5x |
| Fair Price | 609.35 - 923.18 | 779.15 |
| Upside | -18.9% - 22.8% | 3.7% |
| Date | P/E |
| 2026-04-24 | 17.64 |
| 2026-04-23 | 17.98 |
| 2026-04-22 | 17.52 |
| 2026-04-21 | 17.54 |
| 2026-04-20 | 17.59 |
| 2026-04-17 | 17.61 |
| 2026-04-16 | 17.51 |
| 2026-04-15 | 17.69 |
| 2026-04-14 | 17.73 |
| 2026-04-13 | 17.52 |
| 2026-04-10 | 17.57 |
| 2026-04-09 | 18.02 |
| 2026-04-08 | 18.20 |
| 2026-04-07 | 17.84 |
| 2026-04-06 | 17.91 |
| 2026-04-02 | 17.88 |
| 2026-04-01 | 18.24 |
| 2026-03-31 | 18.13 |
| 2026-03-30 | 17.58 |
| 2026-03-27 | 17.31 |
| 2026-03-26 | 17.76 |
| 2026-03-25 | 17.59 |
| 2026-03-24 | 17.41 |
| 2026-03-23 | 17.28 |
| 2026-03-20 | 17.20 |
| 2026-03-19 | 17.31 |
| 2026-03-18 | 17.46 |
| 2026-03-17 | 17.81 |
| 2026-03-16 | 17.76 |
| 2026-03-13 | 17.50 |
| 2026-03-12 | 17.52 |
| 2026-03-11 | 18.18 |
| 2026-03-10 | 18.12 |
| 2026-03-09 | 18.34 |
| 2026-03-06 | 17.83 |
| 2026-03-05 | 17.95 |
| 2026-03-04 | 18.48 |
| 2026-03-03 | 17.99 |
| 2026-03-02 | 18.56 |
| 2026-02-27 | 18.34 |
| 2026-02-26 | 18.09 |
| 2026-02-25 | 18.41 |
| 2026-02-24 | 18.12 |
| 2026-02-23 | 18.47 |
| 2026-02-20 | 18.30 |
| 2026-02-19 | 18.36 |
| 2026-02-18 | 18.59 |
| 2026-02-17 | 18.62 |
| 2026-02-13 | 18.85 |
| 2026-02-12 | 18.39 |